anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Arbutus Biopharma · pitchdeck

Arbutus Biopharma | Investor Presentation Deck | 26 slides

26 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Arbutus Biopharma | Investor Presentation Deck | 26 slides

Arbutus Biopharma · 2024-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 31 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides Agitate 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides Solution 19 slides 100% 19/19 slides 100% 19/19 slides · 89 hits
— 0/19 slides
42.1% 8/19 slides 21.1% 4/19 slides 100% 19/19 slides · 29 hits 42.1% 8/19 slides Evidence & Proof 8 slides 100% 8/8 slides 100% 8/8 slides · 42 hits
— 0/8 slides
37.5% 3/8 slides 25% 2/8 slides 100% 8/8 slides · 16 hits 100% 8/8 slides Impact & Next Steps 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
50% 1/2 slides
— 0/2 slides
100% 2/2 slides · 4 hits
— 0/2 slides

Slide inventory

26
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a simple icon-based visual to anchor the core strategic goal.present_solution
Open slide detail
04
The slide uses a structured grid layout to present high-level value propositions.summarize
Open slide detail
05
The slide uses a Gantt-style visualization to represent drug development stages.plan_implementation
Open slide detail
06
The slide uses a four-column layout to structure the disease overview.establish_context
Open slide detail
07
The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to treated patients.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.present_solution
Open slide detailBeat · Solution
09
transition
Open slide detailBeat · Solution
10
The slide highlights the mechanism of action and key benefits of the drug candidate.present_solution
Open slide detailBeat · Solution
11
Data presented at EASL 2022, AASLD 2022, GHS 2023.analyze_data
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
12
Data presented at EASL 2022. Shows dual-axis line charts for viral load/ALT and bar charts for T-cell frequency.show_traction
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
13
summarize
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
14
The slide outlines a clinical trial protocol with specific patient counts (n=12, n=8) and timeline milestones (weeks 1, 24, 28, 40, 52).plan_implementation
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
15
Data presented at EASL 2023. Includes both a summary table of mean changes and individual patient trajectory charts.analyze_data
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
16
Shows two parallel study arms with randomization at week 24/26.plan_implementation
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
17
Data presented at AASLD 2023; includes both a summary table and a longitudinal line chart with error bars.analyze_data
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
18
Data presented at AASLD 2023. Shows ELISpot results for T cell responses and HBsAg levels.show_traction
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
19
The slide details a specific licensing deal with Qilu Pharmaceutical, including financial terms and geographic scope.show_traction
Open slide detailBeat · Solution
20
transition
Open slide detailBeat · Solution
21
The slide uses a three-column layout to explain the scientific basis and product advantages.present_solution
Open slide detailBeat · Solution
22
Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.show_traction
Open slide detailBeat · Solution
23
The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.plan_implementation
Open slide detailBeat · Solution
24
Includes a footnote regarding the 3/21/2023 Court Scheduling Order.other
Open slide detailBeat · Solution
25
The slide includes a financial disclaimer regarding cash balance and burn.plan_implementation
Open slide detailBeat · Solution
26
state_next_steps
Open slide detailBeat · Solution